Epstein Robert S, Cimen Ali, Benenson Hannah, Aubert Ronald E, Khalid Mona, Sostek Mark B, Salimi Tehseen
Epstein Health, 50 Tice Boulevard Suite 340, Woodcliff Lake, NJ, 07677, USA,
Adv Ther. 2014 Dec;31(12):1263-71. doi: 10.1007/s12325-014-0169-x. Epub 2014 Nov 21.
While opioids have become a standard treatment option for those experiencing moderate to severe chronic pain, side effects of constipation and related symptoms have interfered with their usage in as many as 40-50% of treated patients. Prior research has elucidated the range of these symptoms, but no study has determined which of these symptoms patients most desire improving or whether improving constipation itself by as little as one more bowel movement per week is deemed an important change.
We conducted an online patient survey of 513 participants residing in one of six countries who reported having chronic pain, were taking opioids, and experiencing opioid-induced constipation (OIC) to address these questions.
Respondents rank ordered their preferences and the following eight symptoms generated >80% endorsement as important to improve: improvement in having bowel movements without rectal pain, soft stools that are not loose or watery, regular bowel movements, a reduction in rectal straining, relief from feeling bloated, feeling less fear about having OIC when following their opioid medication regime, a desire to worry less overall about having a bowel movement, and with less 'stomach' area pain. When asked 'how important is it you to have 1 more bowel movement per week", over 90% endorsed it was 'somewhat', 'very', or 'extremely important' with nearly 70% (n = 354) endorsing the 'extremely' or 'very important' response options. In multivariate models, being in more overall pain or reporting fewer than 3 bowel movements per week were found to be independent predictors of the importance.
These results highlight the notable range of OIC symptoms most desired by patients to improve and demonstrate that bowel movements of only one more per week were important to register a meaningful improvement. The latter is particularly helpful for those assessing the minimal clinically important difference in treating this condition.
虽然阿片类药物已成为中度至重度慢性疼痛患者的标准治疗选择,但便秘及相关症状的副作用影响了多达40%-50%接受治疗患者对其的使用。先前的研究已阐明了这些症状的范围,但尚无研究确定患者最希望改善哪些症状,或者每周仅增加一次排便来改善便秘本身是否被视为一项重要改变。
我们对居住在六个国家之一的513名参与者进行了在线患者调查,这些参与者报告患有慢性疼痛、正在服用阿片类药物且患有阿片类药物引起的便秘(OIC),以解决这些问题。
受访者对他们的偏好进行了排序,以下八种症状获得了超过80%的认可,认为对改善病情很重要:排便时无直肠疼痛、大便柔软不稀溏或不成水样、规律排便、直肠用力减少、腹胀缓解、按照阿片类药物治疗方案服药时对患OIC的恐惧减轻、总体上对排便的担忧减少以及“胃部”区域疼痛减轻。当被问及“每周多一次排便对你有多重要”时,超过90%的人认可这“有点”“非常”或“极其重要”,近70%(n = 354)的人选择“极其”或“非常重要”。在多变量模型中,总体疼痛程度更高或每周排便少于3次被发现是重要性的独立预测因素。
这些结果突出了患者最希望改善的OIC症状范围之广,并表明每周仅多一次排便对实现有意义的改善很重要。后者对评估治疗这种疾病的最小临床重要差异特别有帮助。